Trial intelligence / Profile preview

Effect of tranexamic acid on bleeding during femur fracture surgery

IRCT201104256280N1Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in femoral fracture, sponsored by Guilan University of Medical Sciences. Primary endpoint: Intraoperative bleeding volume. Started Jul 2014; status: completed.

02

Drugs

tranexamic acid
03

Conditions

femoral fracture

Beyond the preview

Go deeper on IRCT201104256280N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201104256280N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call